title: [Complete and sustained remission of liver metastases from neuroendocrine tumor with somatostatin analogue therapy].
abstract: Somatostatin analogues represent a major treatment modality in the therapy of neuroendocrine tumors. Their efficacy is well documented in the inhibition of hormone secretion; however, novel data seem to underline their effectiveness in tumor regression, as well. In this report authors present a case of type 1 neuroendocrine tumors of the stomach associated with liver metastases. Somatostatin analogue treatment resulted in a complete regression of the primary tumor and the metastases within two years. This case draws attention on the importance of somatostatin analogue treatment not only in the control of hormonal symptoms but also in the inhibition of tumor growth.
authors.affiliation: Semmelweis Egyetem, Általános Orvostudományi Kar, II. Belgyógyászati Klinika, Budapest.
authors.forename: György
authors.initials: G
authors.lastname: Raizer
authors.forename: Péter
authors.initials: P
authors.lastname: Igaz
authors.forename: István
authors.initials: I
authors.lastname: Pregun
authors.forename: Gabriella
authors.initials: G
authors.lastname: Dabasi
authors.forename: Károly
authors.initials: K
authors.lastname: Rácz
mesh_terms: D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary*; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D015282:Octreotide / Q000627:therapeutic use*; D011877:Radionuclide Imaging; D012074:Remission Induction; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013274:Stomach Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D013004:Somatostatin; C081788:pentetreotide; D015282:Octreotide